[1]王大建.呼吸兴奋剂（尼可刹米+洛贝林）联合纳洛酮与氟马西尼在重度安眠药物中毒抢救治疗中的效果观察[J].医学信息,2018,31(02):128-129，132.[doi:10.3969/j.issn.1006-1959.2018.02.047]
　WANG Da-jian.Curative Effect of Respiratory Stimulant(Nikethamide+Lobelin)Combined with Naloxone and Flumazenil in the Rescue Treatment of Severe Hypnotic Poisoning[J].Journal of Medical Information,2018,31(02):128-129，132.[doi:10.3969/j.issn.1006-1959.2018.02.047]
点击复制

呼吸兴奋剂（尼可刹米+洛贝林）联合纳洛酮与氟马西尼在重度安眠药物中毒抢救治疗中的效果观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
128-129，132
栏目:
药物与临床
出版日期:
2018-01-15

文章信息/Info

Title:
Curative Effect of Respiratory Stimulant(Nikethamide+Lobelin)Combined with Naloxone and Flumazenil in the Rescue Treatment of Severe Hypnotic Poisoning
文章编号:
1006-1959（2018）00-0128-03
作者:
王大建
四川省成都市武侯区第三人民医院重症医学科，四川 成都 610043
Author(s):
WANG Da-jian
Department of Critical Care Medicine,Third People's Hospital of Wuhou,Chengdu 610043,Sichuan,China
关键词:
安眠药物中毒; 氟马西尼; 纳洛酮; 呼吸兴奋剂
Keywords:
Key words：Sleeping pills poisoning; Flumacini; Naloxone; Respiratory stimulant
分类号:
R595.4
DOI:
10.3969/j.issn.1006-1959.2018.02.047
文献标志码:
A
摘要:
目的 研究并探讨呼吸兴奋剂（尼可刹米+洛贝林）联合纳洛酮与氟马西尼在重度安眠药物中毒抢救治疗中的临床疗效。方法 选取2014年1月~2017年8月我科收治的60例重度安眠药物中毒患者，随机分为两组，各30例。对照组采用纳洛酮联合呼吸兴奋剂治疗，观察组采用氟马西尼联合呼吸兴奋剂治疗，两组在疗效、格拉斯哥昏迷指数、催醒时间、住院时间、不良反应等方面作比较。结果 观察组的总有效率（96.67%）明显高于对照组（80.00%），差异具有统计学意义（P＜0.05）；两组治疗后的GCS评分均显著增高，而治疗后观察组的GCS评分高于对照组，差异具有统计学意义（P＜0.05）；观察组的催醒时间、住院时间均短于对照组，差异具有统计学意义（P＜0.05）；两组不良反应相比差异无统计学意义（P＞0.05）。结论 在重度安眠药物中毒患者急诊抢救治疗中，采用呼吸兴奋剂与氟马西尼联合治疗的催醒效果优于纳洛酮+呼吸兴奋剂，可作为重度安眠药物中毒的首选治疗方案。
Abstract:
Abstract：Objective To study and explore the clinical efficacy of respiratory stimulant(nikethamide+Lobeline)combined with naloxone and flumazenil in the treatment of severe hypnotic drug poisoning.Methods From January 2014 to August 2017,60 patients with severe hypnotic drug poisoning admitted to our department were randomly divided into two groups of 30 patients.The control group was treated with naloxone combined with respiratory stimulant.The observation group was treated with flumazenil combined with respiratory stimulant.The two groups were compared in efficacy, Glasgow coma index,wake time,length of hospital stay, and adverse reactions.Results The total effective rate(96.67%)in the observation group was significantly higher than that in the control group(80.00%),the difference was statistically significant(P<0.05);GCS scores of both groups were significantly increased after treatment,but after treatment,GCS score of the observation group was higher than that of the control group,the difference was statistically significant(P<0.05);the awake time and hospitalization time of the observation group were shorter than the control group,the difference was statistically significant(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion In the emergency rescue treatment of patients with severe hypnotic drug poisoning,the combination of respiratory stimulant and flumazenil is better than naloxone+respiratory stimulant,which can be used as the first choice of severe hypnotic drug poisoning treatment programs.

参考文献/References:

[1]霍秋玉.血液灌流和纳洛酮抢救安眠药中毒的疗效观察[J].实用临床医药杂志,2012,16(21):56-58.
[2]李明,肖广辉,阎旸,等.纳洛酮、醒脑静联合治疗老年急性安眠药中毒的疗效及对生活功能的影响[J].中国老年学杂志,2017,37(12):3050-3051.
[3]宋迎春,任国庆.纳美芬与纳洛酮治疗镇静安眠药中毒的临床效果比较[J].山东医药,2014,54(24):107,109.
[4]郑静静.纳洛酮和氟马西尼联用在抢救急性酒精安定混合中毒的疗效和安全性[J].中国医疗前沿,2012,7(11):32-33.
[5]陆悦,李晴晴,张文文,等.洛贝林对恩氟烷麻醉小鼠催醒效果的观察[J].徐州医学院学报,2013,33(8):500-501.
[6]戴山林,金宇.无创正压通气复合尼可刹米治疗Ⅱ型呼吸衰竭合并神志障碍的疗效[J].江苏医药,2013,39(22):2741-2742.
[7]郑增权,牛晓琳.氟马西尼联合纳洛酮和醒脑静救治急性安定中毒的临床观察[J].临床医学研究与实践,2017,2(15):31-32.
[8]王凤永,周良济.纳洛酮联合氟马西尼治疗苯二氮卓类药物中毒的临床研究[J].白求恩医学杂志,2017,15(3):338-339.
[9]郭霞.氟马西尼与纳洛酮抢救苯二氮革类药物急性中毒的疗效比较[J].中国药业,2015,24(20):68-69.

相似文献/References:

[1]李继荣,王志坚,李三清,等.氟马西尼及纳洛酮治疗肝昏迷的疗效比较[J].医学信息,2023,36(09):120.[doi:10.3969/j.issn.1006-1959.2023.09.024]
　LI Ji-rong,WANG Zhi-jian,LI San-qing,et al.Efficacy Comparison of Flumazenil and Naloxone in the Treatment of Hepatic Coma[J].Journal of Medical Information,2023,36(02):120.[doi:10.3969/j.issn.1006-1959.2023.09.024]

更新日期/Last Update: 2018-02-15